CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- DEF 14A Proxy Proxy Statement
- 3/A Insider 3/A
- 4/A Insider Changes in Ownership
- 4 Open-market buy Director bought 14,900 shares at $1.64 ($24,406)
- 4 Open-market buy Director bought 19,491 shares at $1.68 ($32,803)
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-3 Offering Registration Statement
- 8-K Event Material agreement
- 8-K Event Executive or director change
Page 12 of 21 · 420 filings